Weekly Irinotecan Liposomes in Recurrent or Refractory Ewing Sarcoma
Conditions: Ewing Sarcoma Interventions: Drug: Irinotecan Hydrochloride Liposome Injection Sponsors: Peking University People ' s Hospital; Peking University Shougang Hospital; Shandong Cancer Hospital and Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Identification of Prognostic Factors and Role of Radiotherapy in Patients With Ewing Sarcoma
Conditions: Ewing Sarcoma Interventions: Other: clinical records review Sponsors: Istituto Ortopedico Rizzoli Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Cabozantinib With Ifosfamide in Ewing's Sarcoma and Osteosarcoma
Conditions: Ewing Sarcoma; Osteosarcoma Interventions: Drug: Cabozantinib Sponsors: Children ' s Hospital of Philadelphia; Children ' s Hospital Colorado; Exelixis; Alex ' s Lemonade Stand Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
Conditions: Ewing Sarcoma; Rhabdomyosarcoma; Synovial Sarcoma Interventions: Biological: Peptide vaccine IPX Sponsors: University Hospital Tuebingen; Deutsches Konsortium f ürTranslationale Krebsforschung (DKTK); Cooperative Ewing Sarkom Studiengruppe; Cooperative Weichteilsarkom Study Group Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2023 Category: Research Source Type: clinical trials
Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD
Conditions: Ewing Sarcoma; Ewing Sarcoma of Bone; Ewing Sarcoma of Soft Tissue; Peripheral Primitive Neuroectodermal Tumor; Peripheral Primitive Neuroectodermal Tumor of Bone; Peripheral Primitive Neuroectodermal Tumor of Soft Tissue; High-grade Osteosarcoma Interventions: Other: FoundationOne Liquid CDx Sponsors: Dana-Farber Cancer Institute; Alex ' s Lemonade Stand Foundation; Conquer Cancer Foundation; Harvard University; Sam Day Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Condition: Ewing Sarcoma Intervention: Drug: Naxitamab Sponsors: Anna Raciborska; Wroclaw Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma
Condition: Bone Cancer Intervention: Drug: regorafenib tablet Sponsors: Gustave Roussy, Cancer Campus, Grand Paris; Princess Maxima Center for Pediatric Oncology; Bayer Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2023 Category: Research Source Type: clinical trials
